top of page
CONFERENCE PROGRAM 

The AMC2024 conference program features a broad range of speakers across three concurrent sessions covering the entire spectrum of the disease under the key categories of:

  • Early melanoma

  • Advanced melanoma

  • Prevention, risk and clinical detection of melanoma

  • Supportive care and survivorship.

​The program features plenary sessions delivered by speakers at the top of their field, alongside workshops, panel discussions, sponsored sessions, oral scientific and clinical abstract presentations, and ample networking opportunities. Additionally, it includes a debate topic that is sure to provoke thoughtful discussion and lively engagement.
Find out more about our accredited sessions here. 

8.00am - 9.30am

Mezzanine, Maritime 1 - 3

Registration and Welcome Breakfast

(Exhibition and posters)

9.30am - 10.15am

Grand Ballroom

OFFICIAL OPENING
Speakers:

  • Welcome to Country, Uncle Brendan Kerin

  • Opening address, The Hon Mark Butler MP

  • Highlights of melanoma over the years, Prof Georgina Long AO and Prof Richard Scolyer AO

11.00am - 11.30am

Maritime 1 - 3

Morning Tea

(Exhibition and posters)

10.15am - 10.50am

Grand Ballroom

10.50am - 11.00am

Grand Ballroom

PLENARY 1: Beating melanoma: A shared purpose for transformative outcomes
Speaker:

  • Prof Helen Rizos

  

Conquering Skin Cancer Movie Preview​

Speakers:

  • Mike Hill and Sue Collins

Concurrent Sessions 11.30am - 1.00pm

BALLROOM 2

Overview of peri-operative systemic therapies
Chairs:
A/Prof Alexander Menzies and A/Prof Rachel Roberts- Thomson
Speakers: 

  • Neo-adjuvant therapy data and best practice, A/Prof Alexander Menzies

  • Important histopathology considerations, Dr Robert Rawson

  • Surgical considerations,
    Prof David Gyorki

  • Adjuvant therapies including personalised vaccines, Prof Victoria Atkinson

  • Clinical stage II melanoma, A/Prof Rachel Roberts-Thomson

  • Clinical stage III melanoma, A/Prof Ines Silva 

  • Panel discussion: A/Prof Alexander Menzies, Dr Robert Rawson, Prof David Gyorki, Prof Victoria Atkinson and Kate Willis

BALLROOM 1
Misdiagnosis and missed diagnosis: Addressing difficult melanocytic pathology through clinical collaboration
Chairs:
Dr Andrew Colebatch and Dr Louise Jackett
Speakers: 

  • Diagnostic dilemmas,
    Dr Aleodor Andea

  • Case study and panel discussion: Dr Andrew Colebatch, Dr Louise Jackett, Dr Blake O’Brien, Dr David Speakman, Prof Pascale Guitera and Dr Adrian Quek

MARITIME 4
Melanoma in populations: Burden, risk and genes 
Chairs:
Prof Anne Cust and
Prof David Whiteman
Speakers: 

  • Burden of disease / health economics, Dr Daniel Lindsay

  • Incidence and risk factors for second primary melanoma, Yuan Ni

  • Evaluating melanoma risk tools – quantitative and qualitative data for first vs subsequent primary, Dr Amelia Smit

  • Impact of covid comparing Swedish and Victorian data, Prof Rory Wolfe

  • Genetics of melanoma,
    A/Prof Matthew Law

  • Genetic testing for melanoma – evolution and latest guidance, Dr Courtney Wallingford

  • Sex differences in melanoma, Dr Nina Afshar

1.00pm - 2.00pm

Maritime 1 - 3

Lunch

(Exhibition and posters)

Concurrent Sessions 2.00pm - 3.30pm

BALLROOM 2

Digital imaging and decision making for melanoma
Chairs:
Prof Victoria Mar and A/Prof Tony Caccetta
Speakers: 

  • Part 1: Overview and evidence, Dr Helena Collgros

  • Interactive cases, Dr Bruna Gouveia and Dr Alex Chamberlain

  • Part 2: Overview and evidence, Dr Helena Collgros

  • Interactive cases, Dr Bruna Gouveia

  • Prognosis, A/Prof Serigne Lo

  • Digital Biomarkers, Prof Victoria Mar

BALLROOM 1

Is there still a role for surgery in early stage melanoma?
Chairs:
A/Prof Alexander van Akkooi and Prof David Gyorki
Speakers: 

  • Current evidence on Gene Expression Profiling (GEP) for prognosis and SLNB risk prediction, Prof Susan Swetter

  • Update on the utility of circulating tumour DNA (ctDNA), Dr Jenny Lee

  • Is there still a role for SLNB in the modern era of melanoma management for clinical stage IIB/C melanoma?, Prof Andrew Barbour

  • Panel discussion: Prof Susan Swetter, Dr Jenny Lee, Prof Andrew Barbour, Karen van Gorp

  • Why bother with locoregional therapies in the modern age of melanoma treatment?, A/Prof Alexander van Akkooi

  • Panel discussion 2: A/Prof Alexander van Akkooi, Dr Hayden Snow, Prof Victoria Atkinson and Karen van Gorp

MARITIME 4

Navigating the future of melanoma nursing: Advances in complex care, emerging treatments and toxicity management 
Chairs:
Maria Gonzalez and Alethea Lobo
Speakers: 

  • Addressing complex care needs- the role of specialist oncology nurses, Prof Mei Krishnasamay

  • Treatment sequencing and factors influencing decision making, Kate Willis

  • Neoadjuvant vs. adjuvant -
    the evidence broken down, Maria Gonzalez

  • Neoadjuvant nursing care - important considerations,
    Dr Donna Milne

  • Complex drug toxicities - what nurses need to know, Krista Rubin

  • Case study 1 - Melanie Grimmer

  • Case study 2 - Hayley Burridge

3.30pm - 4.00pm

Maritime 1 - 3

Afternoon Tea

(Exhibition and posters)

Concurrent Sessions 4.00pm - 5.00pm

BALLROOM 2

Multidisciplinary approaches in melanoma: The role of radiation therapy
Chairs:
Prof Angela Hong and Prof Mark Pinkham
Speakers: 

  • RADICAL trial: A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna, Prof Angela Hong

  • The use of confocal microscopy and optical coherence tomography to guide local treatment, Dr Christoph Sinz

  • SRS: Integration with immunotherapy and risk of radionecrosis, Dr Michael Huo

  • The rationale and role of stereotactic body radiotherapy in melanoma, A/Prof Eric Hau

BALLROOM 1
Wellness Session: Mastering confidence: A toolkit for tackling impostor syndrome
Chair:
Matthew Browne
Speaker: 

  • Katharine Collins
    Brought to you by Eau Thermale Avene

Avene logo.png

MARITIME 4

New treatment approaches 
Chairs:
Prof Helen Rizos and Prof
Elin Gray 
Speakers: 

  • Tumor infiltrating lymphocyte therapy in therapy resistant melanoma, Prof Jonas Nilsson

  • Epigenetic Modifiers: A Novel Target for Melanoma Treatment, A/Prof Jason Lee

  • Improving T cell responses against melanoma, A/Prof Jason Waithman

5.25pm - 5.55pm

Grand Ballroom

DEBATE: Patient advocacy and consumer representation are just a tick box exercise
Chairs: Alison Button-Sloan, Rod Flude and Matthew Browne

Speakers:

  • Affirmative: Craig Lawn and Tamara Dawson

  • Negative: Prof Grant McArthur and Prof Rachael Morton

5.55pm - 6.00pm

Grand Ballroom

Closing remarks

Speakers:

  • Prof Georgina Long AO and Prof Richard Scolyer AO

5.00pm - 5.25pm

Maritime 1 - 3

Refreshment Break

6.45pm - 9.45pm

Cafe del Mar

Harbourview Soirée

Speaker:

  • Benjamin Law (from 7:30pm)

MSD logo.png
BMS.png
Medison Logo.png
Pierre Fabre.png

Disclaimer:

All best endeavours will be made to present the program as shown on this website. The Organising Committee reserve the right to alter without prior notice, any of the arrangements, timetables, plans or other items relating to the meeting, for any cause beyond its reasonable control.

The Organising Committee is not liable for any loss or inconvenience caused as a result of such alteration. In the event of unforeseen circumstances, the Organising Committee do not accept responsibility for loss of monies caused by delays.​

Together Amplifying impact.png

The conference is hosted by Melanoma Institute Australia – a non-profit organisation dedicated to preventing and curing melanoma through innovative, world-class research, treatment and education programs.

Our mission is zero deaths from melanoma this decade.

Melanoma Institute Australia

The Poche Centre, 40 Rocklands Rd, Wollstonecraft NSW 2065 Australia

Email: amc2024@melanoma.org.au  Phone: +61 2 9911 7200

  • White Facebook Icon
  • White Twitter Icon
  • White Instagram Icon
bottom of page